Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China

We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical medicine 2020-02, Vol.9 (2), p.571
Hauptverfasser: Boldog, Péter, Tekeli, Tamás, Vizi, Zsolt, Dénes, Attila, Bartha, Ferenc A, Röst, Gergely
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page 571
container_title Journal of clinical medicine
container_volume 9
creator Boldog, Péter
Tekeli, Tamás
Vizi, Zsolt
Dénes, Attila
Bartha, Ferenc A
Röst, Gergely
description We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.
doi_str_mv 10.3390/jcm9020571
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7073711</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2364029251</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-93a14e6ae868b82fbdff3d6c6542246f65a9cb19178a3e3b038a4fe1864843453</originalsourceid><addsrcrecordid>eNpdkV9LwzAUxYMobsy9-AGk4IsI1fxrkr4Io04dDAeivoa0TVy3tplJO_Db27E5p_flXrg_DufeA8A5gjeExPB2kVUxxDDi6Aj0MeQ8hESQ44O5B4beL2BXQlCM-CnoEQxjAinpg_FL4ZfByHvtfaXrJrAmeLZrXQaJdbZW68K1Pkhm75P7EMXBrG1Sp9XSbyZf5DpI5kWtzsCJUaXXw10fgLeH8WvyFE5nj5NkNA0zynETxkQhqpnSgolUYJPmxpCcZSyiGFNmWKTiLEUx4kIRTdLOvaJGI8GooIRGZADutrqrNq10nnWGnSrlyhWVcl_SqkL-3dTFXH7YteSQE45QJ3C1E3D2s9W-kVXhM12Wqta29RITRiGOcbRBL_-hC9u6ujtPYkYRZLj7Zkddb6nMWe-dNnszCMpNQPI3oA6-OLS_R3_iIN802ImG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2641062842</pqid></control><display><type>article</type><title>Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>PubMed Central</source><creator>Boldog, Péter ; Tekeli, Tamás ; Vizi, Zsolt ; Dénes, Attila ; Bartha, Ferenc A ; Röst, Gergely</creator><creatorcontrib>Boldog, Péter ; Tekeli, Tamás ; Vizi, Zsolt ; Dénes, Attila ; Bartha, Ferenc A ; Röst, Gergely</creatorcontrib><description>We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm9020571</identifier><identifier>PMID: 32093043</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Clinical medicine ; Connectivity ; Coronaviruses ; COVID-19 ; Disease transmission ; Epidemics ; Estimates ; Exports ; Infections ; Infectious diseases ; Pneumonia ; Severe acute respiratory syndrome coronavirus 2 ; Travel</subject><ispartof>Journal of clinical medicine, 2020-02, Vol.9 (2), p.571</ispartof><rights>2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-93a14e6ae868b82fbdff3d6c6542246f65a9cb19178a3e3b038a4fe1864843453</citedby><cites>FETCH-LOGICAL-c472t-93a14e6ae868b82fbdff3d6c6542246f65a9cb19178a3e3b038a4fe1864843453</cites><orcidid>0000-0003-1827-7932 ; 0000-0001-9476-3284</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073711/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073711/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32093043$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boldog, Péter</creatorcontrib><creatorcontrib>Tekeli, Tamás</creatorcontrib><creatorcontrib>Vizi, Zsolt</creatorcontrib><creatorcontrib>Dénes, Attila</creatorcontrib><creatorcontrib>Bartha, Ferenc A</creatorcontrib><creatorcontrib>Röst, Gergely</creatorcontrib><title>Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.</description><subject>Clinical medicine</subject><subject>Connectivity</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease transmission</subject><subject>Epidemics</subject><subject>Estimates</subject><subject>Exports</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Pneumonia</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Travel</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkV9LwzAUxYMobsy9-AGk4IsI1fxrkr4Io04dDAeivoa0TVy3tplJO_Db27E5p_flXrg_DufeA8A5gjeExPB2kVUxxDDi6Aj0MeQ8hESQ44O5B4beL2BXQlCM-CnoEQxjAinpg_FL4ZfByHvtfaXrJrAmeLZrXQaJdbZW68K1Pkhm75P7EMXBrG1Sp9XSbyZf5DpI5kWtzsCJUaXXw10fgLeH8WvyFE5nj5NkNA0zynETxkQhqpnSgolUYJPmxpCcZSyiGFNmWKTiLEUx4kIRTdLOvaJGI8GooIRGZADutrqrNq10nnWGnSrlyhWVcl_SqkL-3dTFXH7YteSQE45QJ3C1E3D2s9W-kVXhM12Wqta29RITRiGOcbRBL_-hC9u6ujtPYkYRZLj7Zkddb6nMWe-dNnszCMpNQPI3oA6-OLS_R3_iIN802ImG</recordid><startdate>20200219</startdate><enddate>20200219</enddate><creator>Boldog, Péter</creator><creator>Tekeli, Tamás</creator><creator>Vizi, Zsolt</creator><creator>Dénes, Attila</creator><creator>Bartha, Ferenc A</creator><creator>Röst, Gergely</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1827-7932</orcidid><orcidid>https://orcid.org/0000-0001-9476-3284</orcidid></search><sort><creationdate>20200219</creationdate><title>Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China</title><author>Boldog, Péter ; Tekeli, Tamás ; Vizi, Zsolt ; Dénes, Attila ; Bartha, Ferenc A ; Röst, Gergely</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-93a14e6ae868b82fbdff3d6c6542246f65a9cb19178a3e3b038a4fe1864843453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Clinical medicine</topic><topic>Connectivity</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease transmission</topic><topic>Epidemics</topic><topic>Estimates</topic><topic>Exports</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Pneumonia</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Travel</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boldog, Péter</creatorcontrib><creatorcontrib>Tekeli, Tamás</creatorcontrib><creatorcontrib>Vizi, Zsolt</creatorcontrib><creatorcontrib>Dénes, Attila</creatorcontrib><creatorcontrib>Bartha, Ferenc A</creatorcontrib><creatorcontrib>Röst, Gergely</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boldog, Péter</au><au>Tekeli, Tamás</au><au>Vizi, Zsolt</au><au>Dénes, Attila</au><au>Bartha, Ferenc A</au><au>Röst, Gergely</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2020-02-19</date><risdate>2020</risdate><volume>9</volume><issue>2</issue><spage>571</spage><pages>571-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number R loc ). We found that in countries with low connectivity to China but with relatively high R loc , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low R loc benefit the most from policies that further reduce R loc . Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>32093043</pmid><doi>10.3390/jcm9020571</doi><orcidid>https://orcid.org/0000-0003-1827-7932</orcidid><orcidid>https://orcid.org/0000-0001-9476-3284</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2077-0383
ispartof Journal of clinical medicine, 2020-02, Vol.9 (2), p.571
issn 2077-0383
2077-0383
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7073711
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; PubMed Central
subjects Clinical medicine
Connectivity
Coronaviruses
COVID-19
Disease transmission
Epidemics
Estimates
Exports
Infections
Infectious diseases
Pneumonia
Severe acute respiratory syndrome coronavirus 2
Travel
title Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A44%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20Assessment%20of%20Novel%20Coronavirus%20COVID-19%20Outbreaks%20Outside%20China&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Boldog,%20P%C3%A9ter&rft.date=2020-02-19&rft.volume=9&rft.issue=2&rft.spage=571&rft.pages=571-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm9020571&rft_dat=%3Cproquest_pubme%3E2364029251%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2641062842&rft_id=info:pmid/32093043&rfr_iscdi=true